News
25m
DPA International on MSNResearch shows many people who stop weight loss drugs regain weightPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after stopping their prescription, ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Costa Rica: A recent systematic review published in the Cureus Journal of Medical Science has shed light on the potential of ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
Morrisons has opened its own weight loss subscription, selling tirzepatide injections – also known as Mounjaro – to help ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results